These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10225228)

  • 1. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.
    Hanson IC; Antonelli TA; Sperling RS; Oleske JM; Cooper E; Culnane M; Fowler MG; Kalish LA; Lee SS; McSherry G; Mofenson L; Shapiro DE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):463-7. PubMed ID: 10225228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants.
    Sutthent R; Chokephaibulkit K; Piyasujabul D; Vanprapa N; Roogpisuthipong A; Chaisilwatana P
    J Clin Virol; 2002 Jul; 25(1):47-56. PubMed ID: 12126721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1.
    Sirinavin S S; Phaupradit W; Taneepanichskul S; Atamasirikul K; Hetrakul P; Thakkinstian A; Panburana P
    Int J Infect Dis; 2000; 4(3):148-52. PubMed ID: 11179918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
    Bhoopat L; Khunamornpong S; Lerdsrimongkol P; Sirivatanapa P; Sethavanich S; Limtrakul A; Gomutbuthra V; Kajanavanich S; Thorner PS; Bhoopat T
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):545-50. PubMed ID: 16284530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
    Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
    Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
    Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric HIV clinical trials in the United States.
    Landry S
    NIAID AIDS Agenda; 1997 Nov; ():3-4. PubMed ID: 11364921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
    Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
    Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.